Thomas Christott graduated with a Diploma in Biology (technologically oriented) from the University of Stuttgart, Germany in 2012. He joined ProImmune, Ltd. in Oxford from 2012 to 2015 as an assay scientist, working with the REVEAL and ProVE T-cell epitope discovery platforms as well as their protein purification pipeline.
In July 2015, he returned to the fold of academia and joined the Screening group at the Target Discovery Institute.
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
National SARS-CoV-2 Serology Assay Evaluation Group None., (2020), Lancet Infect Dis, 20, 1390 - 1400